Uncategorized

Arbele, a biotechnology company dedicated to fighting gastrointestinal cancers, celebrates its 7th anniversary and the opening of Tiberias Technology, its accredited lab for cancer screening and in vitro diagnostics, at the Hong Kong Science and Technology Park.

Zynex, Inc., announced the pricing of its previously announced private offering of $52.5 million aggregate principal amount of 5.00% convertible senior notes due 2026 in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

Formosa Pharmaceuticals, Inc. and AimMax Therapeutics, Inc. announce the submission of a New Drug Application to the United States Food & Drug Administration for APP13007, a novel aqueous nanosuspension formulation of the potent corticosteroid, clobetasol propionate, for the treatment of inflammation and pain following ocular surgery.

CANbridge Pharmaceuticals, Inc., a global biopharmaceutical company, with a foundation in China, committed to the research, development and commercialization of transformative therapies to treat rare diseases and oncology, announced that it has appointed Jason West, Ph.D., to the position of Vice President, Head of Gene Therapy Research, effective immediately.

CTI BioPharma Corp. announced that an authorized subcommittee of the Compensation Committee of its Board of Directors granted an equity award to a new employee as an equity inducement award outside of the Company’s Amended and Restated 2017 Equity Incentive Plan and material to the employee’s acceptance of employment with the company.

SI-BONE, Inc., a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced the pricing of its underwritten public offering of 3,775,000 shares of its common stock at a price to the public of $22.00.

Un nuevo análisis de datos recolectados décadas atrás por la sonda espacial Voyager 2 de la NASA, junto con nuevas observaciones realizadas desde la Tierra y modelos digitales, ha llevado a unos científicos de la NASA a concluir que cuatro de las lunas de Urano contienen …

ImmunoGen Inc., a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, announced the pricing of an underwritten public offering of 26,000,000 shares of its common stock at a price of $12.50 per share, before underwriting discounts and commissions.

Transgene, a biotech company that designs and develops virus-based immunotherapeutics against cancer, announced that the Board has appointed Dr Alessandro Riva, MD, as the Company’s new Chairman and CEO to accelerate the development of its innovative immunotherapy portfolio.

Norlase, a leading global ophthalmic laser manufacturer developing next-generation laser solutions, announced it has received both FDA 510 clearance and CE Mark approval for the ECHO Green Pattern Laser photocoagulator.